Life Sciences

Merck updates grand jury investigation, announces denial of class action status for Vioxx suit

Pharma Compliance Alert, March 25, 2009

A grand jury is investigating Merck’s research, marketing, and selling activities for its withdrawn painkiller Vioxx, the company announced.

Merck had previously disclosed the government’s investigation, which began in 2004, but received a letter from the U.S. Attorney's Office for the District of Massachusetts advising it of the probe March 23.

Read more about Merck's announcements about Vioxx.

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Medical Environment Update

    A subscription to Medical Environment Update pays for itself by saving you time sorting through complex regulations and...

  • Bloodborne Pathogens Training Video

    Meets OSHA requirements for training employees on the bloodborne pathogens standard!

  • Healthcare Marketing Advisor

    Healthcare Marketing Advisor provides concise, time-saving strategies for branding, promoting, and advertising your...

  • Needlestick Prevention Training Video

    Highlighting the five most frequent needlestick scenarios, this training video instructs frontline healthcare staff on on...

Most Popular